Patents by Inventor A. Wayne Williams

A. Wayne Williams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250023999
    Abstract: A supply item has toner for use in an imaging device. A chip has memory storing quanta indicating allowed usage of the supply item over its lifetime and a multiplier correlating the quanta to toner mass. The imaging device requires quanta to conduct imaging operations and loads the quanta and multiplier by way of a certificate stored in the memory. The imaging device retrieves quanta from the chip over time and both devices keep tally. Initialization between the supply item and imaging device includes providing encrypted and unencrypted instances of firmware versions and certificates from the supply item that the imaging device can compare for security. Alternatively, the supply item defines a fuser assembly, imaging unit, intermediate transfer member, or other component installed for use in the imaging device.
    Type: Application
    Filed: September 26, 2024
    Publication date: January 16, 2025
    Inventors: STEPHEN PORTER BUSH, NATHAN WAYNE FOLEY, TIMOTHY JOHN RADEMACHER, JENNIFER TOPMILLER WILLIAMS, GREGORY SCOTT WOODS, CHRISTOPHER ALAN ADKINS
  • Patent number: 12193721
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: January 14, 2025
    Assignee: Gyrus ACMI, Inc.
    Inventors: Kester Julian Batchelor, Maureen D. Busche, Wayne Williams
  • Patent number: 12161384
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Grant
    Filed: September 18, 2023
    Date of Patent: December 10, 2024
    Assignee: Gyrus ACMI, Inc.
    Inventors: Kester Julian Batchelor, Riyad Moe, Wayne Williams
  • Publication number: 20240403821
    Abstract: The present invention is a system and method for managing stored things using scannable pieces/devices and a mobile application. The system includes small adhesive scannable pieces that are removably attached to storage spaces, as well as a mobile application that can scan the scannable components to access data on the items kept in the related storage spaces. Users, upon scanning the scannable pieces which contain item lists, find, and manage their stored goods using the mobile application without having to physically open and look through storage spaces. The scannable components are lightweight, adaptable, and simple to attach and detach from storage areas. The method makes things easier for users and can be used for inventory control and item identification in warehouses.
    Type: Application
    Filed: June 5, 2023
    Publication date: December 5, 2024
    Inventor: Wayne A. Williams, JR.
  • Patent number: 12137963
    Abstract: A bipolar surgical instrument comprises a body, first and second opposed jaws located at the distal end of a shaft, the first jaw being movable with respect to the second jaw between an open position in which the first and second jaws are spaced apart from one another, and a closed position in which the first and second jaws are adjacent one another. The first and second elongate jaw members have respective first and second electrodes. A controller is operable to determine a starting voltage for application to the jaws.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: November 12, 2024
    Assignee: GYRUS MEDICAL LIMITED
    Inventors: Wayne Williams, Lewis Jones
  • Publication number: 20240315756
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power-a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Application
    Filed: June 5, 2024
    Publication date: September 26, 2024
    Inventors: Kester Julian Batchelor, Wayne Williams
  • Publication number: 20240305141
    Abstract: Systems, methods, and apparatuses for receiving wireless power using a wireless power receiver client architecture are disclosed. A simplified wireless power receiver apparatus includes an energy storage device and a radio frequency (RF) transceiver including an antenna. Energy harvester circuitry is coupled to the energy storage device and the RF transceiver, and control circuitry is coupled to the energy storage device, the RF transceiver, and the energy harvester. The control circuitry causes the RF transceiver to: establish a connection with a wireless power transmitter (WPT), transmit a beacon signal to the WPT, and receive a wireless power signal from the WPT. The control circuitry causes the energy harvester to deliver at least a portion of energy of the wireless power signal to the energy storage device for storage therein. In some embodiments, a single antenna is utilized both for transmitting the beacon signal and for receiving the wireless power signal.
    Type: Application
    Filed: May 20, 2024
    Publication date: September 12, 2024
    Applicant: Ossia Inc.
    Inventors: Hatem Ibrahim Zeine, Douglas Wayne Williams, James J. Wojcik
  • Patent number: 12059191
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: August 13, 2024
    Assignee: Gyrus ACMI, Inc.
    Inventors: Kester Julian Batchelor, Wayne Williams
  • Patent number: 11990770
    Abstract: Systems, methods, and apparatuses for receiving wireless power using a wireless power receiver client architecture are disclosed. A simplified wireless power receiver apparatus includes an energy storage device and a radio frequency (RF) transceiver including an antenna. Energy harvester circuitry is coupled to the energy storage device and the RF transceiver, and control circuitry is coupled to the energy storage device, the RF transceiver, and the energy harvester. The control circuitry causes the RF transceiver to: establish a connection with a wireless power transmitter (WPT), transmit a beacon signal to the WPT, and receive a wireless power signal from the WPT. The control circuitry causes the energy harvester to deliver at least a portion of energy of the wireless power signal to the energy storage device for storage therein. In some embodiments, a single antenna is utilized both for transmitting the beacon signal and for receiving the wireless power signal.
    Type: Grant
    Filed: November 3, 2022
    Date of Patent: May 21, 2024
    Assignee: Ossia Inc.
    Inventors: Hatem Ibrahim Zeine, Douglas Wayne Williams, James J. Wojcik
  • Publication number: 20240156509
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Application
    Filed: December 13, 2023
    Publication date: May 16, 2024
    Inventors: Kester Julian Batchelor, Wayne Williams
  • Patent number: 11944368
    Abstract: A bipolar surgical instrument comprises a body, first and second opposed jaws located at the distal end of a shaft, the first jaw being movable with respect to the second jaw between an open position in which the first and second jaws are spaced apart from one another, and a closed position in which the first and second jaws are adjacent one another. The first and second elongate jaw members have respective first and second electrodes. A controller is operable to detect a short circuit between the first and second electrodes when in use.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: April 2, 2024
    Assignee: GYRUS MEDICAL LIMITED
    Inventors: Wayne Williams, Lewis Jones
  • Patent number: 11941071
    Abstract: Disclosed are methods, systems, and non-transitory computer-readable medium for a web-based process to generate electronic checklists and deploy electronic checklists. One method may include: receiving bulk data from a user device; parsing the bulk data to form a loadable database for an electronic procedure system of a vehicle; generating a rendering of an electronic checklist of one or more electronic checklists based on the loadable database; transmitting a first message to the user device, the first message including the rendering of the electronic checklist; iteratively performing an authoring process using a web-based tool to update the loadable database; receiving a second message from the user device, the second message including an instruction to transmit the updated loadable database to the electronic procedure system of the vehicle; and transmitting a third message to the vehicle, the third message including the updated loadable database.
    Type: Grant
    Filed: January 31, 2023
    Date of Patent: March 26, 2024
    Assignee: Honeywell International Inc.
    Inventors: Cody Ryan Conaway, Timothy R. DeWitt, Kevin Wayne Williams
  • Patent number: 11918274
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: March 5, 2024
    Assignee: Gyrus ACMI, Inc.
    Inventors: Kester Julian Batchelor, Wayne Williams
  • Publication number: 20240065747
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Application
    Filed: September 18, 2023
    Publication date: February 29, 2024
    Inventors: Kester Julian Batchelor, Riyad Moe, Wayne Williams
  • Patent number: 11914731
    Abstract: Aspects described herein relate to securely performing cross-boundary backup operations. A service of a computing resource service provider may enable backup operations between a source account and a destination account of an organization based at least in part on a security policy allowing such operations.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: February 27, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Ivan Velickovic, Alexander Sirotin, Christopher John Schilling, Steven Robert DeVos, Zhicong Wang, Wayne William Duso, Boo Boon Khoo
  • Patent number: 11901366
    Abstract: A flat panel substrate with integrated antennas and wireless power transmission system for delivering power to a receiving device is presented herein. A method can comprise depositing, onto a flat panel substrate, an antenna layer comprising multiple adaptively phased antennas elements; and depositing, onto the flat panel substrate, respective thin film transistor (TFT)-based antenna management circuits for the multiple adaptively phased antenna elements—the respective TFT-based antenna management circuits being operable to measure respective first phases at which first signals are received at the multiple adaptively phased antenna elements, and based on the respective first phases, control respective second phases at which second signals are transmitted from the multiple adaptively phased antenna elements to facilitate delivery, via the second signals, of power to the receiving device.
    Type: Grant
    Filed: February 10, 2023
    Date of Patent: February 13, 2024
    Assignee: Ossia Inc.
    Inventors: Hatem Ibrahim Munir Zeine, Douglas Wayne Williams, Adam W. Oster
  • Patent number: 11883088
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: January 30, 2024
    Assignee: Gyrus ACMI, Inc.
    Inventors: Kester Julian Batchelor, Wayne Williams
  • Patent number: 11868765
    Abstract: In a computer-implemented method for automatically presenting a visualization of information within a terminal for interfacing with a distributed version control system, an input is received at a command line interface of a terminal for interfacing with a distributed version control system, the input including an operation to be performed by the distributed version control system. The operation to be performed by the distributed version control system is identified based on the input. The operation is executed to generate output of the operation. The output is displayed within the command line interface. A graphical visualization of the output is automatically displayed within a visualization pane of the terminal, wherein the graphical visualization is interactive.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: January 9, 2024
    Assignee: Axosoft, LLC
    Inventors: James Pitts, Justin Roberts, Michael Swindell, Wayne Williams, Hamid Shojaee
  • Patent number: 11864813
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: January 9, 2024
    Assignee: Gyrus ACMI, Inc.
    Inventors: Kester Julian Batchelor, Riyad Moe, Wayne Williams
  • Publication number: 20240000495
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Application
    Filed: June 21, 2023
    Publication date: January 4, 2024
    Inventors: Kester Julian Batchelor, Maureen Julian Batchelor, Wayne Williams